GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 632 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $46,000 | -75.4% | 1,000 | -71.4% | 0.04% | -72.7% |
| Q2 2014 | $187,000 | +192.2% | 3,494 | +191.2% | 0.13% | +265.7% |
| Q1 2014 | $64,000 | -25.6% | 1,200 | -25.0% | 0.04% | +2.9% |
| Q4 2013 | $86,000 | -94.5% | 1,600 | -94.9% | 0.03% | -84.2% |
| Q3 2013 | $1,572,000 | -75.9% | 31,400 | -76.0% | 0.22% | -74.5% |
| Q2 2013 | $6,534,000 | – | 130,800 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |